AstraZeneca and Daiichi Sankyo ’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the ...

The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis pigmentosa (XLRP).

Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) technology.

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

ITM Radiopharma’s Phase III trial of its targeted radiotherapeutic for patients with Grade 1 or 2 gastroenteropancreatic ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.